145 related articles for article (PubMed ID: 10471427)
1. Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
Pfefferkorn TK; Knüppel HP; Jaeger BR; Thiery J; Hamann GF
Stroke; 1999 Sep; 30(9):1802-6. PubMed ID: 10471427
[TBL] [Abstract][Full Text] [Related]
2. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
5. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
Jaeger BR
Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
[TBL] [Abstract][Full Text] [Related]
6. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
[TBL] [Abstract][Full Text] [Related]
7. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
Park JW; Merz M; Braun P
Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
Mo JK; Li YX; Lei D; Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
[TBL] [Abstract][Full Text] [Related]
9. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
10. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
[TBL] [Abstract][Full Text] [Related]
11. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
12. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
13. Heparin-mediated extracorporeal LDL/fibrinogen precipitation--H.E.L.P.--in coronary and cerebral ischemia.
Jaeger BR; Marx P; Pfefferkorn T; Hamann G; Seidel D
Acta Neurochir Suppl; 1999; 73():81-4. PubMed ID: 10494346
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced extracorporal low-density-lipoprotein precipitation (H.E.L.P.) to improve the recovery of hearing in patients with sudden idiopathic hearing loss.
Suckfüll M; Wimmer C; Jäger B; Schorn K; Thiery J
Eur Arch Otorhinolaryngol; 2000; 257(2):59-61. PubMed ID: 10784362
[TBL] [Abstract][Full Text] [Related]
15. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
[TBL] [Abstract][Full Text] [Related]
16. Reopening of internal carotid artery occlusions during heparin-induced LDL precipitation (H.E.L.P.) associated with improved haemorheology: report of 2 cases.
Walzl M; Niederkorn K; Walzl B; Horner S; Lechner H
Wien Klin Wochenschr; 1993; 105(12):350-4. PubMed ID: 8333205
[TBL] [Abstract][Full Text] [Related]
17. Six years of treatment with the HELP system of a patient with familial hypercholesterolemia.
Nascimento MM; Pasqual DD; dos Santos JE; Riella MC
Braz J Med Biol Res; 2002 Jul; 35(7):775-82. PubMed ID: 12131916
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia.
Eisenhauer T; Armstrong VW; Schuff-Werner P; Schütz E; Thiery J; Scheler F; Seidel D
ASAIO Trans; 1989; 35(3):580-3. PubMed ID: 2597539
[TBL] [Abstract][Full Text] [Related]
19. Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study.
Pfefferkorn T; von Stuckrad-Barre S; Herzog J; Gasser T; Hamann GF; Dichgans M
Stroke; 2001 Jan; 32(1):17-21. PubMed ID: 11136908
[TBL] [Abstract][Full Text] [Related]
20. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
Schuff-Werner P
Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
